{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:30:12Z","timestamp":1793115012030,"version":"4.5.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.autrev.2023.103329","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T17:57:38Z","timestamp":1681408658000},"page":"103329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Autoimmune disorders caused by intravesical bacillus Calmette-Guerine treatment: A systematic review"],"prefix":"10.1016","volume":"22","author":[{"given":"Omer","family":"Anis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Yogev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arad","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishai M.","family":"Tsur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicktoria","family":"Vishnevskia Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menachem","family":"Laufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103329_bb0005","series-title":"Cancer Today","author":"IARC","year":"2021"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/joim.13195","article-title":"Good old BCG \u2013 what a century-old vaccine can contribute to modern medicine","volume":"288","author":"Locht","year":"2020","journal-title":"J Intern Med"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2023.103329_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000052375","article-title":"BCG’s mechanism of action – Increasing our understanding","volume":"37","author":"Bohle","year":"2000","journal-title":"Eur Urol"},{"issue":"Supplement_3","key":"10.1016\/j.autrev.2023.103329_bb0020","doi-asserted-by":"crossref","DOI":"10.1086\/314064","article-title":"Efficacy and safety of Bacille Calmette-Gu\u00e9rin immunotherapy in superficial bladder Cancer","volume":"31","author":"Lamm","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2023.103329_bb0025","author":"R Core Team"},{"issue":"10","key":"10.1016\/j.autrev.2023.103329_bb0030","first-page":"599","article-title":"Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report","volume":"49","author":"Shiba","year":"2003","journal-title":"Hinyokika Kiyo"},{"issue":"5","key":"10.1016\/j.autrev.2023.103329_bb0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1078-1439(03)00012-7","article-title":"Bacillus Calmete-Gu\u00e9rin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity","volume":"21","author":"Lam","year":"2003","journal-title":"Urol Oncol"},{"issue":"11","key":"10.1016\/j.autrev.2023.103329_bb0040","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/rheumatology\/34.11.1097","article-title":"Psoriatic arthropathy after BCG immunotherapy for bladder carcinoma","volume":"34","author":"Queiro","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7326\/0003-4819-117-6-537_1","article-title":"Arthritis after bacillus Calmette-Guerin therapy","volume":"117","author":"Puett","year":"1992","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103329_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10396-018-0889-7","article-title":"Ultrasonographic findings in a patient with reactive arthritis induced by intravesical BCG therapy for bladder cancer","volume":"46","author":"Yoshimura","year":"2001","journal-title":"J Med Ultrason"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0055","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s100670200131","article-title":"Two cases of acute polyarthritis secondary to Intravesical BCG adjuvant therapy for superficial bladder Cancer","volume":"21","author":"Pardalidis","year":"2002","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.biopha.2007.05.004","article-title":"Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement","volume":"61","author":"Brandau","year":"2007","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0065","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/jid.2015.45","article-title":"Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death","volume":"135","author":"Armstrong","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103329_bb0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/1319-2442.225178","article-title":"A case of renal granulomatosis with polyangiitis following intravesical bacillus Calmette-Gu\u00e9rin therapy","volume":"29","author":"Selmi","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0022-5347(17)45606-0","article-title":"Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer","volume":"135","author":"Lamm","year":"1986","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/21548331.1994.11443033","article-title":"Polyarthritis in an elderly man with bladder Cancer","volume":"29","author":"Varoqua","year":"1994","journal-title":"Hosp Pract"},{"issue":"3","key":"10.1016\/j.autrev.2023.103329_bb0085","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/clinids\/17.3.526","article-title":"Reiter\u2019s syndrome after administration of Intravesical Bacille Calmette-Guerin","volume":"17","author":"Faus","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.autrev.2023.103329_bb0090","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/rheumatology\/32.11.1018","article-title":"Reactive arthritis associated with Bacillus Calmette-Guerin immunotherapy for carcinoma of the bladder: a report of two cases","volume":"32","author":"Jawad","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2023.103329_bb0095","first-page":"1485","article-title":"Reactive arthritis associated with bacillus Calmette-Gu\u00e9rin immunotherapy for carcinoma of the bladder: immune reactivity against mycobacterial antigens","volume":"23","author":"Miossec","year":"1996","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103329_bb0100","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.reuma.2011.11.009","article-title":"Reactive arthritis after the intravesical instillation of BCG","volume":"8","author":"Mac\u00eda Villa","year":"2012","journal-title":"Reumatol Clin"},{"issue":"5","key":"10.1016\/j.autrev.2023.103329_bb0105","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/ard.48.5.432","article-title":"Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder","volume":"48","author":"Hughes","year":"1989","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2023.103329_bb0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2217\/ijr.14.41","article-title":"Reactive arthritis following Bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"9","author":"Cardozo","year":"2014","journal-title":"Int J Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103329_bb0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2169\/internalmedicine.56.7494","article-title":"Henoch Sch\u00f6nlein Purpura nephritis associated with Intravesical Bacillus Calmette-Guerin (BCG) therapy","volume":"56","author":"Tsukada","year":"2017","journal-title":"Intern Med"},{"issue":"11","key":"10.1016\/j.autrev.2023.103329_bb0120","doi-asserted-by":"crossref","first-page":"882","DOI":"10.7326\/0003-4819-112-11-882_2","article-title":"Arthritis after Mycobacterium bovis immunotherapy for bladder Cancer","volume":"112","author":"Ochsenk\u00fchn","year":"1990","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5114\/reum.2019.87617","article-title":"Polymyalgia rheumatica and remitting seronegative symmetrical synovitis with pitting edema following intravesical instillation of bacillus Calmette-Guerin","volume":"57","author":"Manzo","year":"2019","journal-title":"Reumatologia."},{"issue":"8","key":"10.1016\/j.autrev.2023.103329_bb0130","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.medmal.2017.05.010","article-title":"Systemic Bacillus Calmette-Guerin sepsis manifesting as autoimmunity, 17 months after an intravesical BCG-therapy","volume":"47","author":"Goulabchand","year":"2017","journal-title":"Med Mal Infect"},{"issue":"46","key":"10.1016\/j.autrev.2023.103329_bb0135","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008757","article-title":"New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: a case report and literature review","volume":"96","author":"Takizawa","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/CMR.17.2.348-369.2004","article-title":"HLA-B27-associated reactive arthritis: Pathogenetic and clinical considerations","volume":"17","author":"Colmegna","year":"2004","journal-title":"CMR."},{"issue":"3","key":"10.1016\/j.autrev.2023.103329_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/jaut.2000.0494","article-title":"Bcg and autoimmunity: another two-edged sword","volume":"16","author":"Shoenfeld","year":"2001","journal-title":"J Autoimmun"},{"issue":"3\u20134","key":"10.1016\/j.autrev.2023.103329_bb0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaut.2009.09.007","article-title":"Self heat-shock protein 65-mediated regulation of autoimmune arthritis","volume":"33","author":"Durai","year":"2009","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0155","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0022-5347(17)37668-1","article-title":"Intravesical Evans strain BCG therapy: quantitative Immunohistochemical analysis of the immune response within the Bladder Wall","volume":"147","author":"Prescott","year":"1992","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/08860220601098961","article-title":"Nephrotic syndrome as a complication of intravesical BCG treatment of transitional cell carcinoma of urinary bladder","volume":"29","author":"Singh","year":"2007","journal-title":"Ren Fail"},{"issue":"1","key":"10.1016\/j.autrev.2023.103329_bb0165","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s13104-017-2606-9","article-title":"Poncet\u2019s disease after the intravesical instillation of Bacillus Calmette-Gu\u00e9rin (BCG): a case report","volume":"10","author":"Sampaio","year":"2017","journal-title":"BMC Res Notes"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/24725625.2021.1877381","article-title":"Intestinal ulcers induced by intravesical bacillus Calmette-Gu\u00e9rin therapy","volume":"5","author":"Tsuchiya","year":"2021","journal-title":"Mod Rheumatol Case Rep"},{"issue":"11","key":"10.1016\/j.autrev.2023.103329_bb0175","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/ard.58.11.661","article-title":"Reactive or infectious arthritis","volume":"58","author":"Kuipers","year":"1999","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0180","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4103\/jcrt.JCRT_890_20","article-title":"Bacillus Calmette-Gu\u00e9rin-induced perinuclear antineutrophil cytoplasmic antibodies associated vasculitis in bladder cancer","volume":"17","author":"Kocak","year":"2021","journal-title":"J Cancer Res Ther"},{"issue":"suppl_3","key":"10.1016\/j.autrev.2023.103329_bb0185","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfx140.SP082","article-title":"SP082P-ANCA (POSITIVE)VASCULITIS FOLLOWING INTRAVESICAL INSTILLATION OF BACILLUS CALMETTE-GUERIN","volume":"32","author":"Kudu","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"6944","key":"10.1016\/j.autrev.2023.103329_bb0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.308.6944.1638","article-title":"Arthritis as a complication of intravesical BCG vaccine","volume":"308","author":"Devlin","year":"1994","journal-title":"BMJ."},{"issue":"11","key":"10.1016\/j.autrev.2023.103329_bb0195","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/rheumatology\/34.11.1097","article-title":"Psoriatic arthropathy after BCG immunotherapy for bladder carcinoma","volume":"34","author":"Queiro","year":"1995","journal-title":"Br J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0200","doi-asserted-by":"crossref","first-page":"267","DOI":"10.23938\/ASSN.0875","article-title":"Unusual evolution of reactive arthritis after endovesical immunotherapy with BCG","volume":"43","author":"Hern\u00e1ndez Fern\u00e1ndez","year":"2020","journal-title":"An Sist Sanit Navar"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0205","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1464-410X.1995.tb00788.x","article-title":"Acute reactive polyarthritis after intravesical bacillus Calmette-Gu\u00e8rin instillation","volume":"76","author":"Hammadeh","year":"1995","journal-title":"Br J Urol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103329_bb0210","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s100670050059","article-title":"Polyarthritis as a complication of intravesical bacillus Calmette-Guerin immunotherapy for bladder cancer","volume":"18","author":"Onur","year":"1999","journal-title":"Clin Rheumatol"},{"issue":"37","key":"10.1016\/j.autrev.2023.103329_bb0215","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1055\/s-2002-34066","article-title":"Chronic reactive arthritis associated with Calmette-Gu\u00e9rin bacillus","volume":"127","author":"Neumayr","year":"2002","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"10.1016\/j.autrev.2023.103329_bb0220","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1297-319X(01)00350-5","article-title":"Articular manifestations after the administration of intravesical BCG","volume":"69","author":"Mas","year":"2002","journal-title":"Joint Bone Spine"},{"issue":"8","key":"10.1016\/j.autrev.2023.103329_bb0225","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.revmed.2010.01.010","article-title":"Acute reactive arthritis after intravesical instillation of bacillus Calmette-Gu\u00e9rin. Two case reports and literature review","volume":"31","author":"Miranda","year":"2010","journal-title":"Rev Med Interne"},{"issue":"8","key":"10.1016\/j.autrev.2023.103329_bb0230","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00365540510035300","article-title":"Henoch-Sch\u00f6nlein purpura after intravesical administration of bacillus Calmette-Gu\u00e9rin","volume":"37","author":"Nan","year":"2005","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"10.1016\/j.autrev.2023.103329_bb0235","first-page":"230","article-title":"Dactilitis and oligoarthritis after BCG immunotherapy in a patient affected by bladder cancer","volume":"58","author":"Manzini","year":"2006","journal-title":"Reumatismo."},{"issue":"10","key":"10.1016\/j.autrev.2023.103329_bb0240","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/rheumatology\/41.10.1119","article-title":"Reactive arthritis after BCG immunotherapy: T cell analysis in peripheral blood and synovial fluid","volume":"41","author":"Bartolome Pacheco","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0245","first-page":"933","article-title":"Bacillus Calmette-Gu\u00e9rin associated arthropathy mimicking undifferentiated spondyloarthropathy","volume":"26","author":"Schwartzenberg","year":"1999","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2023.103329_bb0250","first-page":"1825","article-title":"Arthritis after Calmette-Guerin bacillus immunotherapy for bladder cancer","volume":"19","author":"Goupille","year":"1992","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0255","first-page":"752","article-title":"Synovial membrane cytokine profiles in reactive arthritis secondary to intravesical bacillus Calmette-Gu\u00e9rin therapy","volume":"24","author":"Smith","year":"1997","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0260","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10067-005-0157-2","article-title":"Remitting seronegative symmetrical synovitis pitting oedema after BCG instillation","volume":"25","author":"El Mahou","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0265","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/01.rhu.0000231379.70786.01","article-title":"Acute polyarthritis after bacilli Calmette-Guerin intravesical therapy for bladder carcinoma","volume":"12","author":"Moutzouris","year":"2006","journal-title":"J Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103329_bb0270","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2169\/naika.93.1000","article-title":"Polyarthritis caused by intravesical Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer","volume":"93","author":"Asayama","year":"2004","journal-title":"Nippon Naika Gakkai Zasshi"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0275","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.therap.2019.01.011","article-title":"Unusual evolution of reactive arthritis induced by BCG therapy","volume":"74","author":"Slouma","year":"2019","journal-title":"Therapie."},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0280","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00296-005-0059-2","article-title":"Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review","volume":"26","author":"Tinazzi","year":"2006","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0285","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1111\/j.1756-185X.2012.01735.x","article-title":"Response to treatment with tocilizumab of reactive arthritis induced by intravesical bacillus Galmette-Gu\u00e9rin unresponsive to DMARDs","volume":"15","author":"Kwan","year":"2012","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0290","first-page":"657","article-title":"Arthritis following intravesical instillation of BCG for urothelial cancers","volume":"95","author":"Minei","year":"2004","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"issue":"927","key":"10.1016\/j.autrev.2023.103329_bb0295","first-page":"37","article-title":"Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder","volume":"105","author":"Chapman","year":"1992","journal-title":"N Z Med J"},{"issue":"10","key":"10.1016\/j.autrev.2023.103329_bb0300","first-page":"475","article-title":"Acute oligo-arthritis in a patient treated with BCG therapy for bladder carcinoma","volume":"27","author":"Fond","year":"1998","journal-title":"Presse Med"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0305","first-page":"195","article-title":"Three cases of arthritis after BCG therapy for bladder cancer","volume":"12","author":"Goupille","year":"1994","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103329_bb0310","first-page":"684","article-title":"New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy","volume":"7","author":"Dudelzak","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"27","key":"10.1016\/j.autrev.2023.103329_bb0315","first-page":"3231","article-title":"Arthritis after BCG treatment of bladder cancer. A rare complication","volume":"116","author":"R\u00f8devand","year":"1996","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.autrev.2023.103329_bb0320","first-page":"29","article-title":"Polyarthritis as a rare complication in BCG immunoprophylaxis of urinary bladder cancer","volume":"5","author":"Varentsov","year":"1999","journal-title":"Urologiia."},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0325","first-page":"158","article-title":"Intravesical BCG and arthritis","volume":"100","author":"Ort\u00ed","year":"1993","journal-title":"Med Clin (Barc)"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0330","first-page":"162","article-title":"Polyarthritis in 4 patients treated with intravesical BCG-therapy for carcinoma of the bladder","volume":"60","author":"Belmatoug","year":"1993","journal-title":"Rev Rhum Ed Fr"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0335","first-page":"459","article-title":"Acute polyarthritis after BCG-therapy for bladder carcinoma in a patient with ankylosing spondylitis","volume":"62","author":"Thepot","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0340","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1138-3593(06)73249-X","article-title":"Artritis reactiva secundaria a inmunoterapia intravesical con bacilo de Calmette-Guerin","volume":"32","author":"Henares Garc\u00eda","year":"2006","journal-title":"SEMERGEN - Med Familia"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0345","doi-asserted-by":"crossref","first-page":"383","DOI":"10.37201\/req\/155.2020","article-title":"Uncommon adverse events of intravesical Bacillus Calmette-Gu\u00e9rin treatment: a report of three cases","volume":"34","author":"Topuz","year":"2021","journal-title":"Rev Esp Quimioter"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0350","doi-asserted-by":"crossref","first-page":"267","DOI":"10.23938\/ASSN.0875","article-title":"Unusual evolution of reactive arthritis after endovesical immunotherapy with BCG","volume":"43","author":"Hern\u00e1ndez Fern\u00e1ndez","year":"2020","journal-title":"An Sist Sanit Navar"},{"key":"10.1016\/j.autrev.2023.103329_bb0355","author":"Amri"},{"key":"10.1016\/j.autrev.2023.103329_bb0360","first-page":"1","article-title":"Effectiveness of steroid pulse therapy for systemic side effects after Bacillus Calmette-Gu\u00e9rin Intravesical instillation therapy: a series of five cases. Koga F, editor","volume":"2021","author":"Umemoto","year":"2021","journal-title":"Case Rep Urol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103329_bb0365","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.5489\/cuaj.4759","article-title":"Case: Bacillus Calmette-Guerin (BCG)-induced Reiter syndrome with an attempt at repeat BCG induction","volume":"12","author":"Cheung","year":"2018","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"10.1016\/j.autrev.2023.103329_bb0370","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4274\/uob.915","article-title":"A rare side effect of Intravesical Bacillus Calmette-Gu\u00e9rin therapy: reactive arthritis","volume":"17","author":"K\u0131z\u0131lg\u00f6k","year":"2018","journal-title":"uob."},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10384-012-0120-0","article-title":"Bilateral orbital inflammation following intravesical bacille Calmette-Gu\u00e9rin immunotherapy for bladder cancer","volume":"56","author":"Takeuchi","year":"2012","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103329_bb0380","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/s10165-003-0272-3","article-title":"Reiter\u2019s syndrome following intravesical bacille biliE de Calmette-GuErin treatment for superficial bladder carcinoma: report of six cases","volume":"14","author":"Murata","year":"2004","journal-title":"Mod Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103329_bb0385","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/RHU.0000000000000309","article-title":"Arthritis after Intravesical instillation of Bacillus Calmette-Guerin: a patient with an unusually severe clinical course treated with a combined anti-inflammatory and Antimycobacterial regimen","volume":"21","author":"Ani\u0107","year":"2015","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0390","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0210-4806(07)73655-0","article-title":"Polyarthritis secondary to intravesical BCG instillation, a case report","volume":"31","author":"Rinc\u00f3n Mayans","year":"2007","journal-title":"Actas Urol Esp"},{"issue":"10","key":"10.1016\/j.autrev.2023.103329_bb0395","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1097\/OPX.0000000000000682","article-title":"Bilateral iritis after vaccine for bladder Cancer","volume":"92","author":"Parafita-Fern\u00e1ndez","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"8","key":"10.1016\/j.autrev.2023.103329_bb0400","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s10067-006-0393-0","article-title":"Reiter\u2019s syndrome during intravesical BCG therapy for bladder carcinoma","volume":"26","author":"Tektonidou","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0405","doi-asserted-by":"crossref","DOI":"10.1136\/bjo.86.6.706","article-title":"Bilateral uveitis after intravesical BCG immunotherapy for bladder carcinoma","volume":"86","author":"Wertheim","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103329_bb0410","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/rheumatology\/32.12.1096","article-title":"Reiter\u2019s syndrome after intravesical Bacillus Calmette-Gu\u00e9rin treatment for superficial bladder carcinoma","volume":"32","author":"Pancaldi","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103329_bb0415","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/00365599709070359","article-title":"Epididymo-orchitis and Reiter\u2019s disease. Two infrequent complications after intravesical bacillus Calmette-Gu\u00e9rin therapy","volume":"31","author":"Hansen","year":"1997","journal-title":"Scand J Urol Nephrol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0420","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/00365599709070334","article-title":"Reiter syndrome following intracavitary BCG administration","volume":"31","author":"Saporta","year":"1997","journal-title":"Scand J Urol Nephrol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0425","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s13691-018-0342-1","article-title":"Reiter\u2019s syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma: a report of five cases","volume":"7","author":"Nakagawa","year":"2018","journal-title":"Int Cancer Conf J"},{"issue":"902","key":"10.1016\/j.autrev.2023.103329_bb0430","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/pgmj.76.902.791","article-title":"Reiter\u2019s syndrome following intravesical BCG immunotherapy","volume":"76","author":"Hogarth","year":"2000","journal-title":"Postgrad Med J"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0435","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.asjsur.2014.01.016","article-title":"Reiter\u2019s syndrome postintravesical Bacillus Calmette-Gu\u00e9rin instillations","volume":"40","author":"Ng","year":"2017","journal-title":"Asian J Surg"},{"issue":"7","key":"10.1016\/j.autrev.2023.103329_bb0440","first-page":"1699","article-title":"Remitting seronegative symmetrical synovitis with pitting edema following intravesical bacillus Calmette-Gu\u00e9rin instillation","volume":"28","author":"Mouly","year":"2001","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103329_bb0445","article-title":"Reactive arthritis - a rare complication of Intravesical BCG instillation","volume":"7","author":"Freixa","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0450","first-page":"238","article-title":"REITER\u2019S syndrome following INTRAVASICAL BCG therapy for urothelial carcinoma. Summary of CASE reports OVER the past 13 years in Japan, including our current 6 cases","volume":"106","author":"Koike","year":"2015","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"10.1016\/j.autrev.2023.103329_bb0455","first-page":"2014","article-title":"Reactive arthritis induced by intravesical BCG therapy for bladder cancer","author":"Ben Abdelghani","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"12","key":"10.1016\/j.autrev.2023.103329_bb0460","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.autrev.2013.06.017","article-title":"Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature","volume":"12","author":"Bernini","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0465","first-page":"115","article-title":"Polyarthritis following intravesical BCG immunotherapy. Report of a case and review of 26 cases in the literature","volume":"66","author":"Clavel","year":"1999","journal-title":"Rev Rhum Engl Ed"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0470","first-page":"111","article-title":"Reiter\u2019s syndrome following intravesical instillation of Bacillus Calmette-Guerin","volume":"56","author":"Okamoto","year":"2010","journal-title":"Hinyokika Kiyo"},{"issue":"8","key":"10.1016\/j.autrev.2023.103329_bb0475","first-page":"503","article-title":"Reactive polyarthritis induced by intravesical BCG therapy for carcinoma of the bladder","volume":"2","author":"Xerri","year":"1993","journal-title":"Eur J Med"},{"issue":"3","key":"10.1016\/j.autrev.2023.103329_bb0480","first-page":"240","article-title":"Reiter\u2019s syndrome after intravesical Bacillus Calmette-Gu\u00e9rin therapy for bladder cancer","volume":"2","author":"Hodish","year":"2000","journal-title":"Isr Med Assoc J"},{"issue":"12","key":"10.1016\/j.autrev.2023.103329_bb0485","first-page":"941","article-title":"Reiter syndrome after intravesical BCG therapy","volume":"60","author":"Nesher","year":"1993","journal-title":"Rev Rhum Ed Fr"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0490","first-page":"106","article-title":"Refractory arthropathy after intravesical bacillus Calmette-Gu\u00e9rin therapy. Usefulness of isoniazide","volume":"66","author":"Milas","year":"1999","journal-title":"Rev Rhum Engl Ed"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0495","article-title":"Intravesical bacillus Calmette\u2013Gu\u00e9rin therapy for bladder carcinoma causing bilateral ocular inflammation","volume":"3","author":"Sahdev","year":"2017","journal-title":"Int J Educ Res Health Sci"},{"issue":"9","key":"10.1016\/j.autrev.2023.103329_bb0500","first-page":"356","article-title":"Relapsing Reiter\u2019s syndrome after Bacillus Calmette-Gu\u00e9rin immunotherapy for bladder carcinoma","volume":"121","author":"Pego","year":"2003","journal-title":"Med Clin (Barc)"},{"issue":"10","key":"10.1016\/j.autrev.2023.103329_bb0505","first-page":"2010","article-title":"Arthritis and iritis after bacillus Calmette-Gu\u00e9rin therapy","volume":"22","author":"Missioux","year":"1995","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103329_bb0510","first-page":"564","article-title":"Arthritis and iritis after BCG therapy for bladder cancer","volume":"21","author":"Price","year":"1994","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0515","first-page":"235","article-title":"Incomplete Reiter syndrome caused by BCG instillation\u00a0: a case report","volume":"59","author":"Nonomura","year":"2013","journal-title":"Hinyokika Kiyo"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0520","first-page":"345","article-title":"A seventy-four-year-old man with bilateral conjunctival hyperemia, urinary symptoms, and secondary reactive arthritis following the administration of the BCG vaccine","volume":"144","author":"Valenzuela-Su\u00e1rez","year":"2008","journal-title":"Gac Med Mex"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0525","first-page":"162","article-title":"Polyarthritis in 4 patients treated with intravesical BCG-therapy for carcinoma of the bladder","volume":"60","author":"Belmatoug","year":"1993","journal-title":"Rev Rhum Ed Fr"},{"issue":"8","key":"10.1016\/j.autrev.2023.103329_bb0530","first-page":"329","article-title":"Reactive arthritis during the second course of Intravesical BCG therapy requiring Administration of Methotrexate\u00a0: a case report","volume":"63","author":"Ikeuchi","year":"2017","journal-title":"Hinyokika Kiyo"},{"issue":"10","key":"10.1016\/j.autrev.2023.103329_bb0535","first-page":"1083","article-title":"Reiter syndrome: atypical complication of treatment with BCG","volume":"52","author":"Resel Folkersma","year":"1999","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.autrev.2023.103329_bb0540","series-title":"Artrite reattiva a immunoterapia con BCG: a proposito di tre nuovi casi","author":"Passio","year":"2007"},{"issue":"12","key":"10.1016\/j.autrev.2023.103329_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2009.05.021","article-title":"Uveitis in a patient treated with Bacille-Calmette-Gu\u00e9rin: possible antigenic mimicry of mycobacterial and retinal antigens","volume":"116","author":"Garip","year":"2009","journal-title":"Ophthalmology."},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0550","first-page":"1011","article-title":"Severe uveitis followed by reactive arthritis after bacillus Calmette-Gu\u00e9rin therapy","volume":"26","author":"Chevrel","year":"1999","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0555","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/09273948.2010.486099","article-title":"Bilateral panuveitis following intravesical BCG immunotherapy for bladder carcinoma","volume":"18","author":"Uppal","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.autrev.2023.103329_bb0560","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2003-38179","article-title":"Chorioretinitis induced by intravesical Bacillus Calmette-Gu\u00e9rin (BCG) instillations for urinary bladder carcinoma","volume":"220","author":"Guex-Crosier","year":"2003","journal-title":"Klin Monbl Augenheilkd"},{"issue":"7","key":"10.1016\/j.autrev.2023.103329_bb0565","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/bjo.2004.065359","article-title":"Autoimmune retinopathy associated with intravesical BCG therapy","volume":"89","author":"Sharan","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103329_bb0570","article-title":"Panuveitis following intravesical bacille Calmette-Guerin therapy","volume":"29","author":"Jacob","year":"2006","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.autrev.2023.103329_bb0575","first-page":"23","article-title":"Unilateral panuveitis following intravesical therapy with bacille of Calmette et Guerin","volume":"320","author":"Loukil","year":"2012","journal-title":"Bull Soc Belge Ophtalmol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103329_bb0580","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ceo.12252","article-title":"Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma","volume":"42","author":"Cugati","year":"2014","journal-title":"Clin Experiment Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0585","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/0974-620X.99374","article-title":"Bilateral symmetrical corneal melting following intravesical Bacille Calmette-Guerin therapy for bladder carcinoma","volume":"5","author":"Chakraborty","year":"2012","journal-title":"Oman J Ophthalmol"},{"key":"10.1016\/j.autrev.2023.103329_bb0590","series-title":"Intravesical BCG causing bilateral panuveitis and optic neuritis","first-page":"45","volume":"1(1\u20134)","author":"Akhter","year":"2013"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0595","first-page":"481","article-title":"Cryoglobulinemia vasculitis following intravesical instillations of bacillus Calmette-Guerin","volume":"22","author":"Granel","year":"2004","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0600","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/517091","article-title":"Cryoglobulinemia after Intravesical administration of Bacille Calmette-Gu\u00e9rin","volume":"26","author":"Durand","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2023.103329_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.484282","article-title":"Progressive cerebral small vessel disease caused by an autoimmune response to Intravesical Bacille-Calmette-Gu\u00e9rin treatment","volume":"11","author":"Becker","year":"2020","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0610","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/IPC.0b013e31825aedc1","article-title":"Rheumatoid arthritis, Vasculitis, and Mononeuritis multiplex after BCG used in a patient with bladder carcinoma: case report and review of the literature","volume":"20","author":"Reznikova","year":"2012","journal-title":"Infect Dis Clin Pract"},{"issue":"suppl_3","key":"10.1016\/j.autrev.2023.103329_bb0615","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfx140.SP082","article-title":"SP082P-ANCA (POSITIVE)VASCULITIS FOLLOWING INTRAVESICAL INSTILLATION OF BACILLUS CALMETTE-GUERIN","volume":"32","author":"Kudu","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.autrev.2023.103329_bb0620","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/ndt\/gfk071","article-title":"Acute granulomatous tubulointerstitial nephritis caused by intravesical BCG","volume":"21","author":"Kennedy","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.autrev.2023.103329_bb0625","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9343(03)00398-X","article-title":"Sj\u00f6gren\u2019s-like syndrome following intravesical bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"115","author":"Narv\u00e1ez","year":"2003","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.autrev.2023.103329_bb0630","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dsi.2012.03.001","article-title":"New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette\u2013Guerin","volume":"30","author":"Hung","year":"2012","journal-title":"Dermatol Sin"},{"issue":"1","key":"10.1016\/j.autrev.2023.103329_bb0635","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/mus.26328","article-title":"New onset of seropositive generalized myasthenia gravis following intravesical bacille Calmette-Guerin treatment for bladder cancer: a case study","volume":"59","author":"Davalos","year":"2019","journal-title":"Muscle Nerve"},{"issue":"7229","key":"10.1016\/j.autrev.2023.103329_bb0640","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.320.7229.219","article-title":"Systemic granulomatous disease after intravesical BCG instillation","volume":"320","author":"Mooren","year":"2000","journal-title":"BMJ."},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0645","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/2013.jamadermatol.729","article-title":"Worsening of bullous pemphigoid following bacillus Calmette-Gu\u00e9rin treatment for bladder cancer","volume":"149","author":"Johnson","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0650","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/24725625.2021.1877381","article-title":"Intestinal ulcers induced by intravesical bacillus Calmette-Gu\u00e9rin therapy","volume":"5","author":"Tsuchiya","year":"2021","journal-title":"Mod Rheumatol Case Rep"},{"issue":"2018","key":"10.1016\/j.autrev.2023.103329_bb0655","first-page":"1","article-title":"Transitory spontaneous remission of myelodysplasia in an elderly man while receiving Intravesical Bacillus Calmette-Gu\u00e9rin for bladder Cancer: a case report and review of the literature","author":"Murray","year":"2018","journal-title":"Case Rep Hematol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0660","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000500978","article-title":"Combined application of Nivolumab and Intravesical Bacillus Calmette-Gu\u00e9rin led to acute-onset type 1 diabetes","volume":"12","author":"Fujiu","year":"2019","journal-title":"Case Rep Oncol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103329_bb0665","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00000658-197010000-00018","article-title":"Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy","volume":"172","author":"Morton","year":"1970","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0670","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0675","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/joim.13037","article-title":"Clinical and molecular insights into BCG immunotherapy for melanoma","volume":"288","author":"Kremenovic","year":"2020","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103329_bb0680","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder Cancer (ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103329_bb0685","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000453397","article-title":"Cellular innate immunity: an old game with new players","volume":"9","author":"Gasteiger","year":"2017","journal-title":"J Innate Immun"},{"issue":"6284","key":"10.1016\/j.autrev.2023.103329_bb0690","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.autrev.2023.103329_bb0695","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.autrev.2023.103329_bb0700","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41585-020-0346-4","article-title":"Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer","volume":"17","author":"van Puffelen","year":"2020","journal-title":"Nat Rev Urol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0705","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1189\/jlb.4MA0215-059R","article-title":"Long-term in vitro and in vivo effects of \u03b3-irradiated BCG on innate and adaptive immunity","volume":"98","author":"Arts","year":"2015","journal-title":"J Leukoc Biol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103329_bb0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004485","article-title":"Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer","volume":"10","author":"Buffen","year":"2014","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.autrev.2023.103329_bb0715","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ncb1007-1102","article-title":"Autophagosome formation: core machinery and adaptations","volume":"9","author":"Xie","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103329_bb0720","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/iid3.9","article-title":"Relative contribution of IL-1\u03b1, IL-1\u03b2 and TNF to the host response to mycobacterium tuberculosis and attenuated M. bovis BCG","volume":"1","author":"Bourigault","year":"2013","journal-title":"Immun Inflamm Dis"},{"issue":"3","key":"10.1016\/j.autrev.2023.103329_bb0725","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.juro.2013.01.050","article-title":"HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Gu\u00e9rin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Gu\u00e9rin","volume":"190","author":"Zhang","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.autrev.2023.103329_bb0730","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fimmu.2018.00298","article-title":"The potential role of trained immunity in autoimmune and autoinflammatory disorders","volume":"9","author":"Arts","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103329_bb0735","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/bju.15276","article-title":"Value of tumour-infiltrating immune cells in predicting response to intravesical BCG in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"127","author":"Kardoust Parizi","year":"2021","journal-title":"BJU Int"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:28:45Z","timestamp":1761600525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":147,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1568997223000630"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103329","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune disorders caused by intravesical bacillus Calmette-Guerine treatment: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103329"}}